FdaApplication
ANDA 210449
Identifiers
- fda_app_no: ANDA210449
Properties
| Property | Value |
|---|---|
| applicant_name | APOTEX INC |
| application_type | ANDA |
| approval_date | 2026-04-14 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CANAGLIFLOZIN | CANAGLIFLOZIN | 100MG | TABLET;ORAL |
| CANAGLIFLOZIN | CANAGLIFLOZIN | 300MG | TABLET;ORAL |
2 products